|
1
|
Jemal A, Thun MJ, Ries LA, Howe HL, Weir
HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, et al: Annual
report to the nation on the status of cancer, 1975–2005, featuring
trends in lung cancer, tobacco use, and tobacco control. J Natl
Cancer Inst. 100:1672–1694. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wightman B, Ha I and Ruvkun G:
Posttranscriptional regulation of the heterochronic gene lin-14 by
lin-4 mediates temporal pattern formation in C. elegans. Cell.
75:855–862. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hutvágner G and Zamore PD: RNAi: Nature
abhors a double-strand. Curr Opin Genet Dev. 12:225–232. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ketting RF, Fischer SE, Bernstein E, Sijen
T, Hannon GJ and Plasterk RH: Dicer functions in RNA interference
and in synthesis of small RNA involved in developmental timing in
C. elegans. Genes Dev. 15:2654–2659. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ, et al: A microRNA polycistron as a potential human
oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang WC, Liu J, Xu X and Wang G: The role
of microRNAs in lung cancer progression. Med Oncol. 30:675–683.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saito M, Schetter AJ, Mollerup S, Kohno T,
Skaug V, Bowman ED, Mathé EA, Takenoshita S, Yokota J, Haugen A, et
al: The association of microRNA expression with prognosis and
progression in early-stage, non-small cell lung adenocarcinoma: A
retrospective analysis of three cohorts. Clin Cancer Res.
17:1875–1882. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Malleter M, Jacquot C, Rousseau B,
Tomasoni C, Juge M, Pineau A, Sakanian V and Roussakis C: miRNAs, a
potential target in the treatment of non-small-cell lung
carcinomas. Gene. 506:355–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Raponi M, Dossey L, Jatkoe T, Wu X, Chen
G, Fan H and Beer DG: MicroRNA classifiers for predicting prognosis
of squamous cell lung cancer. Cancer Res. 69:5776–5783. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin PY, Yu SL and Yang PC: MicroRNA in
lung cancer. Br J Cancer. 103:1144–1148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koeck S, Amann A, Huber JM, Gamerith G,
Hilbe W and Zwierzina H: The impact of metformin and salinomycin on
transforming growth factor β-induced epithelial-to-mesenchymal
transition in non-small cell lung cancer cell lines. Oncol Lett.
11:2946–2952. 2016.PubMed/NCBI
|
|
16
|
Hou FQ, Lei XF, Yao JL, Wang YJ and Zhang
W: Tetraspanin 1 is involved in survival, proliferation and
carcinogenesis of pancreatic cancer. Oncol Rep. 34:3068–3076. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He Z, Huang C, Lin G and Ye Y:
siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits
the invasion of human lung cancer SPC-A1 cells. Oncol Rep.
35:1933–1940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ouchi Y, Banno Y, Shimizu Y, Ando S,
Hasegawa H, Adachi K and Iwamoto T: Reduced adult hippocampal
neurogenesis and working memory deficits in the Dgcr8-deficient
mouse model of 22q11.2 deletion-associated schizophrenia can be
rescued by IGF2. J Neurosci. 33:9408–9419. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Santiago-Gómez A, Barrasa JI, Olmo N,
Lecona E, Burghardt H, Palacín M, Lizarbe MA and Turnay J:
4F2hc-silencing impairs tumorigenicity of HeLa cells via modulation
of galectin-3 and β-catenin signaling, and MMP-2 expression.
Biochim Biophys Acta. 1833:2045–2056. 2013. View Article : Google Scholar
|
|
20
|
Hu T, Chang YF, Xiao Z, Mao R, Tong J,
Chen B, Liu GC, Hong Y, Chen HL, Kong SY, et al: miR-1 inhibits
progression of high-risk papillomavirus-associated human cervical
cancer by targeting G6PD. Oncotarget. 7:86103–86116.
2016.PubMed/NCBI
|
|
21
|
Hu T, Zhang C, Tang Q, Su Y, Li B, Chen L,
Zhang Z, Cai T and Zhu Y: Variant G6PD levels promote tumor cell
proliferation or apoptosis via the STAT3/5 pathway in the human
melanoma xenograft mouse model. BMC Cancer. 22(13): 2512013.
View Article : Google Scholar
|
|
22
|
He Z, Xia Y, Liu B, Qi X, Li Z, Wang J,
Chen L and Chen Y: Down-regulation of miR-452 is associated with
poor prognosis in the non-small-cell lung cancer. J Thorac Dis.
8:894–900. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kasinski AL and Slack FJ: Epigenetics and
genetics. MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Y, Gao D and Huang L: In vivo
delivery of miRNAs for cancer therapy: challenges and strategies.
Adv Drug Deliv Rev. 81C:128–141. 2011.
|
|
27
|
Zhou J1, Yu L, Gao X, Hu J, Wang J, Dai Z,
Wang JF, Zhang Z, Lu S, Huang X, Wang Z, et al: Plasma microRNA
panel to diagnose hepatitis B virus-related hepatocellular
carcinoma. J Clin Oncol. 29:4781–4788. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vriens MR, Weng J, Suh I, Huynh N,
Guerrero MA, Shen WT, Duh QY, Clark OH and Kebebew E: MicroRNA
expression profiling is a potential diagnostic tool for thyroid
cancer. Cancer. 118:3426–3432. 2012. View Article : Google Scholar
|
|
29
|
Guo J, Miao Y, Xiao B, Huan R, Jiang Z,
Meng D and Wang Y: Differential expression of microRNA species in
human gastric cancer versus non-tumorous tissues. J Gastroenterol
Hepatol. 24:652–657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jian Q, An Q, Zhu D, Hui K, Liu Y, Chi S
and Li C: MicroRNA 340 is involved in UVB-induced dendrite
formation through the regulation of RhoA expression in melanocytes.
Mol Cell Biol. 34:3407–3420. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagata S and Golstein P: The Fas death
factor. Science. 267:1449–1456. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wyllie AH, Kerr JF and Currie AR: Cell
death: The significance of apoptosis. Int Rev Cytol. 68:251–306.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thompson CB: Apoptosis in the pathogenesis
and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Y, Xu KP, Jiang D, Zhao J, Ge JF and
Zheng SY: Relationship of Fas, FasL, p53 and bcl-2 expression in
human non-small cell lung carcinomas. Int J Clin Exp Pathol.
8:13978–13986. 2015.
|
|
35
|
Forde PM and Ettinger DS: Targeted therapy
for non-small-cell lung cancer: Past, present and future. Expert
Rev Anticancer Ther. 13:745–758. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Frisch SM, Schaller M and Cieply B:
Mechanisms that link the oncogenic epithelial-mesenchymal
transition to suppression of anoikis. J Cell Sci. 126:21–29. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choi YH, Burdick MD, Strieter BA, Mehrad B
and Strieter RM: CXCR4, but not CXCR7, discriminates metastatic
behavior in non-small cell lung cancer cells. Mol Cancer Res.
12:38–47. 2014. View Article : Google Scholar :
|
|
38
|
Jin Y, Li F, Zheng C, Wang Y, Fang Z, Guo
C, Wang X, Liu H, Deng L, Li C, et al: NEDD9 promotes lung cancer
metastasis through epithelial-mesenchymal transition. Int J Cancer.
134:2294–2304. 2014. View Article : Google Scholar
|
|
39
|
Xu LJ, Wang YC, Lan HW, Li J and Xia T:
Grb2-associated binder-2 gene promotes migration of non-small cell
lung cancer cells via Akt signaling pathway. Am J Transl Res.
8:1208–1217. 2016.PubMed/NCBI
|
